MeSH term | MeSH ID | Detail |
---|---|---|
Arteriosclerosis | D001161 | 86 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Arteriosclerosis | D001161 | 86 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Pancreatic Neoplasms | D010190 | 77 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Fraser IS et al. | Vaginal epithelial surface appearances in women using vaginal rings for contraception. | 2000 | Contraception | pmid:10802278 |
Bständig B et al. | Effectiveness of low dose of gonadotropin releasing hormone agonist on hormonal flare-up. | 2000 | J. Assist. Reprod. Genet. | pmid:10806591 |
Teede HJ et al. | Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis. | 2000 | Arterioscler. Thromb. Vasc. Biol. | pmid:10807761 |
Owens D et al. | Lipoproteins and low-dose estradiol replacement therapy in post-menopausal Type 2 diabetic patients: the effect of addition of norethisterone acetate. | 2000 | Diabet. Med. | pmid:10821298 |
Verhoeven CH et al. | Excretion balance and metabolism of the progestagen Org 30659 in healthy postmenopausal women. | 2000 | J. Steroid Biochem. Mol. Biol. | pmid:10822023 |
El Bouhmadi A et al. | 100 mg acetylsalicylic acid acutely decreases red cell aggregation in women taking oral contraceptives. | 2000 | Clin. Hemorheol. Microcirc. | pmid:10831061 |
Ozsener S et al. | The effect of continuous combined oral estradiol and norethisterone on the renal and internal carotid artery pulsatility indices in postmenopausal women. | 2000 | Int J Gynaecol Obstet | pmid:10854874 |
Vecchi A et al. | Steroid contraceptive agents and immunological reactivity in experimental animals. | 1976 | Biomedicine | pmid:1086685 |
Ylikorkala O et al. | Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy. | 2000 | Clin Ther | pmid:10868559 |
Ravinder P et al. | Biological efficacy and plasma norethisterone levels of orally administered norethisterone enanthate in rat and hamster. | 1998 | Indian J. Physiol. Pharmacol. | pmid:10874348 |